Terms: = Lymphoma AND TAL1, TCL5, 6886, ENSG00000162367, SCL, P17542, tal-1 AND Clinical Outcome
4 results:
1. Harnessing the MYB-dependent tal1 5'super-enhancer for targeted therapy in T-ALL.
Smith C; Touzart A; Simonin M; Tran-Quang C; Hypolite G; Latiri M; Andrieu GP; Balducci E; Dourthe MÉ; Goyal A; Huguet F; Petit A; Ifrah N; Baruchel A; Dombret H; Macintyre E; Plass C; Ghysdael J; Boissel N; Asnafi V
Mol Cancer; 2023 Jan; 22(1):12. PubMed ID: 36650499
[TBL] [Abstract] [Full Text] [Related]
2. CARMA1 is required for Notch1-induced NF-κB activation in SIL-tal1-negative T cell acute lymphoblastic leukemia.
Zhang N; Xu J; Wang R; Pan T; Zhang H; Yin L; Yao Y; Xu L; Zhu S; Wu Q; Li Z; Liu X; Xu K; Niu M
J Mol Med (Berl); 2021 Oct; 99(10):1447-1458. PubMed ID: 34223928
[TBL] [Abstract] [Full Text] [Related]
3. Site- and allele-specific polycomb dysregulation in T-cell leukaemia.
Navarro JM; Touzart A; Pradel LC; Loosveld M; Koubi M; Fenouil R; Le Noir S; Maqbool MA; Morgado E; Gregoire C; Jaeger S; Mamessier E; Pignon C; Hacein-Bey-Abina S; Malissen B; Gut M; Gut IG; Dombret H; Macintyre EA; Howe SJ; Gaspar HB; Thrasher AJ; Ifrah N; Payet-Bornet D; Duprez E; Andrau JC; Asnafi V; Nadel B
Nat Commun; 2015 Jan; 6():6094. PubMed ID: 25615415
[TBL] [Abstract] [Full Text] [Related]
4. A multiplex reverse transcriptase-polymerase chain reaction strategy for the diagnostic molecular screening of chimeric genes: a clinical evaluation on 170 patients with acute lymphoblastic leukemia.
Elia L; Mancini M; Moleti L; Meloni G; Buffolino S; Krampera M; De Rossi G; Foà R; Cimino G
Haematologica; 2003 Mar; 88(3):275-9. PubMed ID: 12651265
[TBL] [Abstract] [Full Text] [Related]
